Correlation Between Mekonomen and Immunovia Publ

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mekonomen and Immunovia Publ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mekonomen and Immunovia Publ into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mekonomen AB and Immunovia publ AB, you can compare the effects of market volatilities on Mekonomen and Immunovia Publ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mekonomen with a short position of Immunovia Publ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mekonomen and Immunovia Publ.

Diversification Opportunities for Mekonomen and Immunovia Publ

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mekonomen and Immunovia is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Mekonomen AB and Immunovia publ AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovia publ AB and Mekonomen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mekonomen AB are associated (or correlated) with Immunovia Publ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovia publ AB has no effect on the direction of Mekonomen i.e., Mekonomen and Immunovia Publ go up and down completely randomly.

Pair Corralation between Mekonomen and Immunovia Publ

Assuming the 90 days trading horizon Mekonomen is expected to generate 1.03 times less return on investment than Immunovia Publ. But when comparing it to its historical volatility, Mekonomen AB is 8.01 times less risky than Immunovia Publ. It trades about 0.03 of its potential returns per unit of risk. Immunovia publ AB is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,898  in Immunovia publ AB on September 4, 2024 and sell it today you would lose (2,810) from holding Immunovia publ AB or give up 96.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mekonomen AB  vs.  Immunovia publ AB

 Performance 
       Timeline  
Mekonomen AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mekonomen AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mekonomen is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Immunovia publ AB 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Immunovia publ AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Immunovia Publ sustained solid returns over the last few months and may actually be approaching a breakup point.

Mekonomen and Immunovia Publ Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mekonomen and Immunovia Publ

The main advantage of trading using opposite Mekonomen and Immunovia Publ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mekonomen position performs unexpectedly, Immunovia Publ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovia Publ will offset losses from the drop in Immunovia Publ's long position.
The idea behind Mekonomen AB and Immunovia publ AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities